Balancial is working to bring products to market that cater to individual patient needs. A versatile spectrum of products that enable health professionals to give accurate care.
Our products will soon be in the market, subject to product authorisation by the Danish Medicines Agency.
Yes, provided you have a prescription from your doctor and the products are dispensed by a pharmacy.
Patients taking medicinal cannabis products with THC are advised not to drive. Please discuss with your prescriber if you have any questions or concerns.
All doctors can prescribe the products in the medicinal cannabis pilot programme, but they have no obligation to do so.
All doctors can prescribe magistral preparations of cannabis, but they have no obligation to do so.
Only neurologists are allowed to prescribe Sativex.
In case a doctor applies for a compassionate use permit for Marinol or Nabilone, the Danish Medicines Agency will make a decision for each specific application.
A political agreement has made cannabis products in the pilot programme eligible for reimbursement from 1 January 2019.
Under the agreement, terminally ill patients will be reimbursed at 100% when buying cannabis products in the pilot programme whereas other patients will be reimbursed at 50% up to an annual reimbursement amount of DKK 10,000. The parties have agreed that the reimbursement will be retroactive, allowing for reimbursement of cannabis products bought in 2018. The reimbursement will be paid on a current basis to terminally ill patients from 1 September 2018 and to other patients from the 1st quarter of 2019.